{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00225901: Phase 1/Phase 2 Interventional Unknown status Liver Failure, Acute
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01800721: Not Applicable Interventional Completed HIV
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02859961: Phase 2/Phase 3 Interventional Completed HIV
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:torudokimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04351243: Phase 2 Interventional Completed COVID-19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03855852: Not Applicable Interventional Unknown status Bone Loss, Alveolar
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab envedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sovipostobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03631706: Phase 3 Interventional Completed Non-small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02544438: Phase 1/Phase 2 Interventional Completed Acute Myeloid Leukemia
(2015)
Source URL:
Class:
PROTEIN
